Senior insider sale
SIONNA THERAPEUTICS, INC. — senior position signals high conviction
$85.12M
1.94M shares
ORBIMED ADVISORS LLC plans to sell 1.94M shares of SIONNA THERAPEUTICS, INC. valued at approximately $85.12M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
IPO
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2025 | IPO Cash | 1.08M | — |
| Total | 1.08M | ||
Completed
Units to sell
101.00
Market value
$4.5K
Units to sell
184.64K
Market value
$8.53M
Units to sell
59.77K
Market value
$2.66M
Units to sell
48.55K
Market value
$2.17M
Units to sell
2.95K
Market value
$131.2K
Units to sell
52.40K
Market value
$2.34M
Units to sell
226.91K
Market value
$10.29M
Units to sell
235.86K
Market value
$10.53M
Units to sell
47.81K
Market value
$2.13M
Planned — Approximate Date
Units to sell
1.08M
Market value
$46.33M
Units
1.94M
Value
$85.12M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/27/2026 | 101.00 | $4.5K | — | Completed |
5/11/2026 | 184.64K | $8.53M | — | Completed |
5/8/2026 | 59.77K | $2.66M | — | Completed |
5/7/2026 | 48.55K | $2.17M | — | Completed |
4/20/2026 | 2.95K | $131.2K | — | Completed |
4/17/2026 | 52.40K | $2.34M | — | Completed |
4/16/2026 | 226.91K | $10.29M | — | Completed |
4/15/2026 | 235.86K | $10.53M | — | Completed |
4/14/2026 | 47.81K | $2.13M | — | Completed |
| Planned — Approximate Date | ||||
5/29/2026 | 1.08M | $46.33M | Nasdaq Stock Market | Planned |
| Total | 1.94M | $85.12M | ||